Impaired Intracellular Trafficking Is a Common Disease Mechanism ofPMP22Point Mutations in Peripheral Neuropathies
@article{Naef1999ImpairedIT,
title={Impaired Intracellular Trafficking Is a Common Disease Mechanism ofPMP22Point Mutations in Peripheral Neuropathies},
author={Roland Naef and Ueli Suter},
journal={Neurobiology of Disease},
year={1999},
volume={6},
pages={1-14}
}The most common forms of hereditary motor and sensory neuropathies (HMSN) or Charcot-Marie-Tooth disease (CMT) are associated with mutations affecting myelin genes in the peripheral nervous system. A minor subgroup of CMT type 1A (CMT1A) is caused by point mutations in the gene encoding the peripheral myelin protein 22 (PMP22). To study the mechanisms by which these mutations cause the CMT pathology, we transiently transfected COS7 and Schwann cells with wild-type and PMP22 expression…
127 Citations
The PMP22 Gene and Its Related Diseases
- BiologyMolecular Neurobiology
- 2012
The basic genetics, biochemistry and molecular structure of PMP22 are reviewed, followed by discussion of the current understanding of pathogenic mechanisms involving in the inherited neuropathies with mutations in PMP 22 gene.
Recessive, but not dominant, mutations in peripheral myelin protein 22 gene show unique patterns of aggregation and intracellular trafficking
- BiologyNeurobiology of Disease
- 2004
Alterations in degradative pathways and protein aggregation in a neuropathy model based on PMP22 overexpression
- BiologyNeurobiology of Disease
- 2006
Phenotypic Differences between Peripheral Myelin Protein‐22 (PMP22) and Myelin Protein Zero (P0) Mutations Associated with Charcot‐Marie‐Tooth‐Related Diseases
- BiologyJournal of neuropathology and experimental neurology
- 2003
The studies indicate that different types of PMP22 and P0 mutations are associated with specific intracellular chaperone proteins, including calnexin and BiP, and that these associations can be altered by glycosylation.
Pathomechanisms of mutant proteins in Charcot-Marie-Tooth disease
- BiologyNeuroMolecular Medicine
- 2007
The putative functions and malfunctions of proteins encoded by genes mutated in Charcot-Marie-Tooth disease (CMT; inherited motor and sensory neuropathies) in normal and affected peripheral nerves are reviewed to delineate the detailed molecular functions of the proteins associated with CMT in health and disease.
Molecular alterations resulting from frameshift mutations in peripheral myelin protein 22: Implications for neuropathy severity
- BiologyJournal of neuroscience research
- 2005
Results suggest that a greater potential for PMP22 aggregation is associated with a less severe phenotype, whereas dysregulation of Schwann cell proliferation is linked to severe neuropathy.
Cellular mechanisms of connexin32 mutations associated with CNS manifestations
- BiologyJournal of neuroscience research
- 2002
Results indicate that Cx32 mutants that are associated with a CNS phenotype do not interact with Cx45, but may instead have other toxic effects in oligodendrocytes.
Identification of a New Pmp22 Mouse Mutant and Trafficking Analysis of a Pmp22 Allelic Series Suggesting That Protein Aggregates May Be Protective in Pmp22-Associated Peripheral Neuropathy
- BiologyMolecular and Cellular Neuroscience
- 2002
It is shown that each mutant protein in the allelic series has a unique pattern of intracellular localization in transfected cell lines, and suggests that large Pmp22 aggregates may be protective in this form of peripheral neuropathy.
Molecular basis of inherited neuropathies.
- BiologyCurrent opinion in neurology
- 1999
Overexpression or underexpression of peripheral myelin protein of 22 kDa are causative for the most frequent forms of CMT-CMT1A and hereditary neuropathy with liability to pressure palsies--but the mechanisms that lead to incorrect myelin formation and maintenance are still unknown.
Mutations associated with Charcot–Marie–Tooth disease cause SIMPLE protein mislocalization and degradation by the proteasome and aggresome–autophagy pathways
- BiologyJournal of Cell Science
- 2011
SIMPLE is an early endosomal membrane protein that is highly expressed in the peripheral nerves and Schwann cells and the analysis has identified a transmembrane domain (TMD) embedded within the cysteine-rich (C-rich) region that anchors SIMPLE to the membrane, and suggests that SIMPLE is a post-translationally inserted, C-tail-anchored membrane protein.
References
SHOWING 1-10 OF 74 REFERENCES
Overloaded Endoplasmic Reticulum–Golgi Compartments, a Possible Pathomechanism of Peripheral Neuropathies Caused by Mutations of the Peripheral Myelin Protein PMP22
- BiologyThe Journal of Neuroscience
- 1998
Intacellular transport of wild-type PMP22 and its TrJ and Tr mutant forms in Schwann cells and in a non-neuronal cell line confirmed the different intracellular distribution of the mutant forms, indicating that neither the TrJ nor Tr protein has a dominant-negative effect on the cellular distribution ofWild-typePMP22.
Ultrastructural Distribution of PMP22 in Charcot‐Marie-Tooth Disease Type 1A
- BiologyJournal of neuropathology and experimental neurology
- 1996
The results support the hypothesis that this protein serves multiple functions in Schwann cells, and demonstrate that PMP22, Po protein, and myelin basic protein are present in compact myelin of all patients examined.
Aberrant Protein Trafficking inTremblerSuggests a Disease Mechanism for Hereditary Human Peripheral Neuropathies
- BiologyMolecular and Cellular Neuroscience
- 1997
The naturally occurring mouse mutant Trembler (Tr) represents an animal model for inherited human neuropathies caused by point mutations affecting peripheral myelin protein 22 (PMP22). We describe…
Many facets of the peripheral myelin protein PMP22 in myelination and disease
- BiologyMicroscopy research and technique
- 1998
This review will discuss the current knowledge of PMP22 and its related proteins in the normal organism as well as in disease, and focus on how the function ofPMP 22 and its regulation may be relevant to particular disease mechanisms.
Studies on the effects of altered PMP22 expression during myelination in vitro
- BiologyJournal of neuroscience research
- 1997
Observations indicate that PMP22 is involved more in controlling myelin thickness and stability than in the events determining the initial steps of myelin formation, and that abnormal levels of PMP 22 expression do not impair the early stages of myelination and membrane compaction and do not interfere with the expression of other myelin genes.
The peripheral myelin protein gene PMP–22 is contained within the Charcot–Marie–Tooth disease type 1A duplication
- BiologyNature Genetics
- 1992
It is suggested that increased dosage of the PMP–22 gene may be the cause of CMT1A neuropathy.
Myelin mutants: Model systems for the study of normal and abnormal myelination
- BiologyBioEssays : news and reviews in molecular, cellular and developmental biology
- 1996
With the major developments in gene mapping and cloning it is now relevant to study mutations in a variety of species with the real prospect of defining their molecular basis.
Impaired Differentiation of Schwann Cells in Transgenic Mice with Increased PMP22 Gene Dosage
- BiologyThe Journal of Neuroscience
- 1996
It is proposed that Schwann cells are impaired in their differentiation into the myelinating phenotype, leading to a disorder comparable to severe cases of hereditary motor and sensory neuropathies, and aberrant pmp22 gene copy numbers cause various forms of myelination defects.
Widespread expression of the peripheral myelin protein‐22 gene (pmp22) in neural and non‐neural tissues during murine development
- BiologyJournal of neuroscience research
- 1995
It is confirmed by using in situ hybridization techniques that high levels of PMP22 niRNA are present in maturing peripheral nerves of the 2‐week‐old mouse, a finding consistent with the PNS‐specific defect observed in hereditary peripheral neuropathies, and strongly suggest that PMP 22 serves not only a PNSspecific function but is also of broader biological significance in cell proliferation and/or differentiation.
Evidence for a recessive PMP22 point mutation in Charcot–Marie–Tooth disease type 1A
- Biology, MedicineNature genetics
- 1993
A severely affected CMT1 patient is identified who is a compound heterozygote for a recessive PMP22 point mutation, and a 1.5 Mb deletion in 17p11.2–p12 is identified, suggesting that point mutations in PMP 22 can result in dominant and recessive alleles contributing to CMT 1A.